Work

Sequential personalized neoantigen vaccination following first‐line treatments demonstrates safety and efficacy in advanced hepatocellular carcinoma

Year: 2026

Type: article

Study design: Clinical Trial

Source: International Journal of Cancer

DOI: 10.1002/ijc.70445

Authors: Zhixiong Cai, Liman Qiu, Ling Li, Zhenli Li, Kailiang Zhang, Yan lin, Yang Zhou, Xiuqing Dong, Geng Chen, Rong Xie, Jianhui Lin, Yongyi Zeng, Haijun Yu, Zhuting Fang, Wuhua Guo, Xinhui Huang, Xiaolong Liu

Institutions: Fujian Medical University, Mengchao Hepatobiliary Hospital, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, State Key Laboratory of Drug Research, Fudan University Shanghai Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Fujian Provincial Health Technology Project

Awards: G2567375488, G3684633848, G5411650453, G7481465938

OpenAlex ID: W7138120907

FWCI:

Cites: 11

Cited by:

Related to: